1. Home
  2. TKO vs ELAN Comparison

TKO vs ELAN Comparison

Compare TKO & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TKO Group Holdings Inc.

TKO

TKO Group Holdings Inc.

HOLD

Current Price

$184.40

Market Cap

13.9B

Sector

N/A

ML Signal

HOLD

Logo Elanco Animal Health Incorporated

ELAN

Elanco Animal Health Incorporated

HOLD

Current Price

$24.40

Market Cap

12.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TKO
ELAN
Founded
1980
1954
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.9B
12.4B
IPO Year
2023
2018

Fundamental Metrics

Financial Performance
Metric
TKO
ELAN
Price
$184.40
$24.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
17
10
Target Price
$224.53
$27.89
AVG Volume (30 Days)
1.1M
7.4M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
1.70%
N/A
EPS Growth
11200.00
N/A
EPS
2.46
0.22
Revenue
$4,735,151,000.00
$4,715,000,000.00
Revenue This Year
$23.14
$8.21
Revenue Next Year
$1.05
$5.31
P/E Ratio
$74.93
$111.36
Revenue Growth
68.85
6.22
52 Week Low
$176.00
$17.11
52 Week High
$226.94
$27.98

Technical Indicators

Market Signals
Indicator
TKO
ELAN
Relative Strength Index (RSI) 41.92 51.00
Support Level $180.23 $23.40
Resistance Level $190.19 $25.82
Average True Range (ATR) 5.25 0.63
MACD -1.10 0.15
Stochastic Oscillator 6.27 74.14

Price Performance

Historical Comparison
TKO
ELAN

About TKO TKO Group Holdings Inc.

TKO Group Holdings Inc is a sports and sports entertainment company that operates combat sports and sports entertainment companies. It owns and manages valuable sports and entertainment intellectual property. The company distributes content and monetizes its intellectual property through four activities: Media rights, production, and content, Live events and hospitality, Partnerships and marketing and Consumer products licensing, The company has two reportable segments, UFC and WWE. The company generates majority of revenue from the UFC segment. The UFC segment revenue consists of media rights fees associated with the distribution of its programming content, ticket sales, and site fees associated with the business's international live events.

About ELAN Elanco Animal Health Incorporated

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.

Share on Social Networks: